Association between clozapine-induced agranulocytosis and HLA subtyping.
Lopez-Garcia
Pilar
P
Teresa Rodriguez
Juana
J
De Castro
Pilar
P
Landecho
Ignacio
I
Zapata
Ricardo
R
D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006650:Histocompatibility Testing / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction / Q000706:statistics & numerical data; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy* / Q000276:immunology; D012565:Schizophrenic Psychology; D012569:Schizotypal Personality Disorder / Q000523:psychology
D014150:Antipsychotic Agents; D016179:Granulocyte Colony-Stimulating Factor; D003024:Clozapine